Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
1995 Volume 48 Issue 10 Pages 1073-1075
The structures of WS75624 A and B, novel endothelin converting enzyme inhibitors, were determined to be 1 and 2A, respectively, by a combination of chemical evidence and a series of 2D NMR spectral analyses.
The Journal of Antibiotics, Series A
Already have an account? Sign in here